Elevate At Sabcs 2025 - Search Videos

SABCS 2025: Translating Evidence Into Practice in HR /HER2‑ Breast Cancer

SABCS 2025: Translating Evidence Into Practice in HR /HER2‑ Breast Cancer

SABCS 2025 Summary: ESR1 and PIK3CA Mutant HR /HER- mBC - Clinical and Molecular Landscape

SABCS 2025 Summary: ESR1 and PIK3CA Mutant HR /HER- mBC - Clinical and Molecular Landscape

SABCS 2025 Summary: Noteworthy Abstracts in Breast Cancer Including ELEVATE, lidERA, HER2CLIMB-05, and ASCENT-07 Trials

SABCS 2025 Summary: Noteworthy Abstracts in Breast Cancer Including ELEVATE, lidERA, HER2CLIMB-05, and ASCENT-07 Trials

1.6K views5 months ago

SABCS 2025 Summary: ADC Resistance in Breast Cancer

SABCS 2025 Summary: ADC Resistance in Breast Cancer

SABCS 2025 Highlights: Key Trials Including HER2CLIMB-05 (HER2 ), PATINA, lidERA, EMBER-3, ELEVATE, AMBRE, ASCENT-07 (HR ), and TOPACIO/KEYNOTE-162 (TNBC)

SABCS 2025 Highlights: Key Trials Including HER2CLIMB-05 (HER2 ), PATINA, lidERA, EMBER-3, ELEVATE, AMBRE, ASCENT-07 (HR ), and TOPACIO/KEYNOTE-162 (TNBC)

920 views4 months ago

SABCS 2025: Insights on Key Advances in HR /HER2- Breast Cancer

SABCS 2025: Insights on Key Advances in HR /HER2- Breast Cancer

Highlights in ER Breast Cancer From SABCS 2025

Highlights in ER Breast Cancer From SABCS 2025

SABCS 2025: Previewing New Data in HR /HER2- Breast Cancer

SABCS 2025 Panel Discussion: HR mBC - EMBER-3 and evERA Trials

352 views4 months ago

SABCS 2025 Panel Discussion: HR BC - Adjuvant Giredestrant vs. SoC ET (lidERA Trial)

SABCS 2025 Insights: The Association of Breast Density With Clinicopathological Characteristics & Survival in Patients With Early Stage ER /HER2- Lobular BC

SABCS 2025 Insights: Omitting SLN Biopsy in T1-2, Node-Negative, HR /HER2- eBC - Dutch BOOG 2013-08 5-Year Results

SABCS 2025 Summary: Evolving Data for PALB2, ATM, and CHEK2 Carriers With Breast Cancer

SABCS 2025 Insights: Clinical Outcomes of Invasive Lobular Carcinoma vs. Non-Lobular Breast Cancer Assessed by Pathologists, AI CDH1 Classifier, and AI-Derived TME Biomarkers in TAILORx

New research shared at SABCS 2025 suggests that being physically active may lower breast cancer risk — no matter your reproductive history. In a large UK study, higher activity levels were linked to a lower overall risk of breast cancer, consistent across age at first period, menopause timing, childbirth history, and hormone use. Link in bio for more research updates coming out of San Antonio. #breastcancer #SABCS25 #breastcancersupport #breastcancerawareness #breastcancer #cancerresearch #breas

11K views5 months ago

FacebookBreastcancer.org

ASCENT-03 and ASCENT-04 Sacituzumab Govitecan Safety Data Shared at SABCS 2025 | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

targetedonc.com

SABCS 2024 Summary: eBC Highlights Including GeparDouze & OlympiA

SABCS 2024 Summary: Advancing Breast Cancer Detection With Novel Imaging Technologies

2025 Buick Enclave Avenir First Test: This Premium 3-Row SUV Just Leveled Up

SABCS 2024 Summary: Highlights in Breast Cancer Genomic Testing - A Guide to Precision Treatment

418 viewsJan 17, 2025

SABCS 2024 Summary: Key Updates From the EMBER-3, PATINA, TAILORx, INSEMA, and OlympiA Trials in Breast Cancer Management

907 viewsJan 2, 2025

SABCS 2024 Insights: Impact of Anthracyclines in High Genomic Risk Node-Negative HR /HER2- eBC

731 viewsJan 2, 2025

SABCS 2024 Summary: Efficacy of Sacituzumab Govitecan in HR /HER2- mBC and mTNBC - Clinical Data and Implications

SABCS 2024 Insights: Impact of Ribociclib Dose Reduction on Efficacy in HR /HER2- eBC - Insights From the NATALEE Trial

New findings shared at SABCS suggest that people with HR /HER2- breast cancer who carry a BRCA2 mutation may see added benefit from taking endocrine therapy longer than 5 years. More research is needed, but extended therapy was linked with better disease-free survival in this study. Find more research highlights from SABCS 2025 at the link in our bio. 🔗 #breastcancer #SABCS25 #breastcancersupport #breastcancerawareness #breastcancer #cancerresearch #breastcancersurvivors #breastcancerwarriors #

5.8K views5 months ago

FacebookBreastcancer.org

Breaking news from #SABCS25: Results from the decade-long WISDOM trial are reshaping what we know about breast cancer screening. Researchers compared annual mammography to a personalized, risk-based approach—using comprehensive risk assessment, including genetic testing, to guide when to start, how often to screen, and who may benefit most from prevention strategies. According to BCRF investigator Dr. Laura Esserman, this tailored model aims to ensure women receive screening at the frequency and

3.8K views5 months ago

FacebookThe Breast Cancer Research Foundation

Recap of our time at SBTC Annual Meeting 2025 in Lubbock! What an incredible two days filled with worship, connection, encouragement, and vision for what’s ahead. We’re so thankful for every pastor, church leader, and messenger who joined us and made this year’s gathering so special. 💙 During Monday night’s Sending Celebration at Southcrest Baptist Church, IMB President Paul Chitwood celebrated the SBTC’s strong commitment to Cooperative Program giving — noting that together, we’ve helped IMB m

1.2K views6 months ago

FacebookSouthern Baptists of Texas Convention - SBTC

The 2025 Sabacc For Charity National Tournament season is coming to a close real soon! The Trophies are in and the bounties are ready to be distributed among the winners! @clever3dstudio did an amazing job with these trophies! And also big thank yous to all supporting sponsors that have helped make this debut National Tournament season a big success. @hyperspace.me_ 🧡@offworld_exports 🧡@cantinasurplus🧡 @artanddesi 🧡@rustyrancor🧡 @amrodsarmory | Sabacc For Charity

156 views5 months ago

FacebookSabacc For Charity

sabcs2025_ED11_live

VimeoUT Health San Antonio

sabcs2025_AL2_live

VimeoUT Health San Antonio

See more